These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35652232)

  • 21. Engaging Communities in Cancer Prevention and Control Activity Prioritization through a Statewide Needs Assessment: A Case Study from Nebraska.
    Watanabe-Galloway S; Napit K; McCullough J; Luma LB; Kabayundo J; Carritt NL; Schabloske L; Robinson T; Rohde J; Champion V; LoConte NK; Ratnapradipa KL
    Cancer Prev Res (Phila); 2024 Mar; 17(3):97-106. PubMed ID: 38437585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Addressing Health Disparities Across the Cancer Continuum-a Los Angeles Approach to Achieving Equity.
    Finster LJ; Shirazipour CH; Escobedo LA; Cockburn M; Surani Z; Haile RW
    Front Oncol; 2022; 12():912832. PubMed ID: 35865462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Standardizing Measurement of Social and Behavioral Dimensions of Cancer Prevention and Control to Enhance Outreach and Engagement in NCI-Designated Cancer Centers.
    Gage-Bouchard EA; Rawl SM
    Cancer Epidemiol Biomarkers Prev; 2019 Mar; 28(3):431-434. PubMed ID: 30670459
    [No Abstract]   [Full Text] [Related]  

  • 24. Rutgers Cancer Institute of New Jersey's Community Outreach and Engagement Approach to Cancer Prevention.
    Kinney AY; Stroup AM; Scharf S; Libutti SK
    Cancer Prev Res (Phila); 2023 Nov; 16(11):595-600. PubMed ID: 37908146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of biospecimens in population-based research: a review of the National Cancer Institute's Division of Cancer Control and Population Sciences grant portfolio.
    Carrick DM; Mette E; Hoyle B; Rogers SD; Gillanders EM; Schully SD; Mechanic LE
    Biopreserv Biobank; 2014 Aug; 12(4):240-5. PubMed ID: 25162460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tracking Community Outreach and Engagement Activities among National Cancer Institute-Designated Cancer Centers.
    Burus T; McAfee CR; Hull PC; Leader AE; McNair C
    J Natl Cancer Inst; 2024 Sep; ():. PubMed ID: 39312690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors associated with biomedical research participation within community-based samples across 3 National Cancer Institute-designated cancer centers.
    Barrett NJ; Rodriguez EM; Iachan R; Hyslop T; Ingraham KL; Le GM; Martin K; Haring RC; Rivadeneira NA; Erwin DO; Fish LJ; Middleton D; Hiatt RA; Patierno SR; Sarkar U; Gage-Bouchard EA
    Cancer; 2020 Mar; 126(5):1077-1089. PubMed ID: 31909824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Racial, Ethnic, and Gender Representation in Leadership Positions at National Cancer Institute-Designated Cancer Centers.
    Morgan A; Shah K; Tran K; Chino F
    JAMA Netw Open; 2021 Jun; 4(6):e2112807. PubMed ID: 34097046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Five National Cancer Institute-designated cancer centers' data collection on racial/ethnic minority participation in therapeutic trials: a current view and opportunities for improvement.
    Hawk ET; Habermann EB; Ford JG; Wenzel JA; Brahmer JR; Chen MS; Jones LA; Hurd TC; Rogers LM; Nguyen LH; Ahluwalia JS; Fouad M; Vickers SM
    Cancer; 2014 Apr; 120 Suppl 7(0 7):1113-21. PubMed ID: 24643649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Development of Global Cancer Research at the United States National Cancer Institute.
    Parascandola M; Pearlman PC; Eldridge L; Gopal S
    J Natl Cancer Inst; 2022 Sep; 114(9):1228-1237. PubMed ID: 35640108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A framework and process for community-engaged, mixed-methods cancer needs assessments.
    Burus T; Thompson JR; McAfee CR; Williams LB; Knight JR; Huang B; Kanotra S; Wilhite NP; Russell E; Rogers M; Sorrell CL; Stroebel C; King R; Hull PC
    Cancer Causes Control; 2024 Oct; 35(10):1319-1332. PubMed ID: 38809305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A primer for cancer research programs on defining and evaluating the catchment area and evaluating minority clinical trials recruitment.
    Nguyen LH; Cook ED
    Adv Cancer Res; 2020; 146():219-226. PubMed ID: 32241390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Population Health Assessment in a Community Cancer Center Catchment Area: Triple-Negative Breast Cancer, Alcohol Use, and Obesity in New Castle County, Delaware.
    Siegel SD; Brooks MM; Sims-Mourtada J; Schug ZT; Leonard DJ; Petrelli N; Curriero FC
    Cancer Epidemiol Biomarkers Prev; 2022 Jan; 31(1):108-116. PubMed ID: 34737210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Developing strategies for reducing cancer disparities via cross-institutional collaboration: outreach efforts for the partnership between the Ponce School of Medicine and the Moffitt Cancer Center.
    Gwede CK; Castro E; Brandon TH; McIntyre J; Meade CD; Munoz-Antonia T; Simmons VN; Vadaparampil ST; Jimenez J; Quinn GP
    Health Promot Pract; 2012 Nov; 13(6):807-15. PubMed ID: 22167362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of the National Cancer Act on grant support.
    Kalberer JT
    Cancer Res; 1975 Mar; 35(3):472-81. PubMed ID: 1090361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of National Cancer Institute-designated cancer center status: observed variation in surgical care depends on the level of evidence.
    In H; Neville BA; Lipsitz SR; Corso KA; Weeks JC; Greenberg CC
    Ann Surg; 2012 May; 255(5):890-5. PubMed ID: 22504278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frontiers in cancer epidemiology: a challenge to the research community from the Epidemiology and Genomics Research Program at the National Cancer Institute.
    Khoury MJ; Freedman AN; Gillanders EM; Harvey CE; Kaefer C; Reid BC; Rogers S; Schully SD; Seminara D; Verma M
    Cancer Epidemiol Biomarkers Prev; 2012 Jul; 21(7):999-1001. PubMed ID: 22665580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Research to reality: moving evidence into practice through an online community of practice.
    Farrell MM; La Porta M; Gallagher A; Vinson C; Bernal SB
    Prev Chronic Dis; 2014 May; 11():E78. PubMed ID: 24809364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Communication research at the National Cancer Institute, 2013-2019: a grant portfolio analysis.
    Gaysynsky A; Rising CJ; Trivedi N; Blake KD; Chou WS; Oh A; Vanderpool RC
    Cancer Causes Control; 2021 Dec; 32(12):1333-1345. PubMed ID: 34313875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Geospatial approaches to cancer control and population sciences at the United States cancer centers.
    Korycinski RW; Tennant BL; Cawley MA; Bloodgood B; Oh AY; Berrigan D
    Cancer Causes Control; 2018 Mar; 29(3):371-377. PubMed ID: 29423759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.